Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2007

Open Access 01-12-2007 | Debate

Can asthma control be improved by understanding the patient's perspective?

Authors: Rob Horne, David Price, Jen Cleland, Rui Costa, Donna Covey, Kevin Gruffydd-Jones, John Haughney, Svein Hoegh Henrichsen, Alan Kaplan, Arnulf Langhammer, Anders Østrem, Mike Thomas, Thys van der Molen, J Christian Virchow, Siân Williams

Published in: BMC Pulmonary Medicine | Issue 1/2007

Login to get access

Abstract

Background

Clinical trials show that asthma can be controlled in the majority of patients, but poorly controlled asthma still imposes a considerable burden. The level of asthma control achieved reflects the behaviour of both healthcare professionals and patients. A key challenge for healthcare professionals is to help patients to engage in self-management behaviours with optimal adherence to appropriate treatment. These issues are particularly relevant in primary care, where most asthma is managed. An international panel of experts invited by the International Primary Care Respiratory Group considered the evidence and discussed the implications for primary care practice.

Discussion

Causes of poor control
Clinical factors such as exposure to triggers and concomitant rhinitis are important but so are patient behavioural factors. Behaviours such as smoking and nonadherence may reduce the efficacy of treatment and patients' perceptions influence these behaviours. Perceptual barriers to adherence include doubting the need for treatment when symptoms are absent and concerns about potential adverse effects. Under-treatment may also be related to patients' underestimation of the significance of symptoms, and lack of awareness of achievable control.
Implications
Three key implications for healthcare professionals emerged from the debate. First, the need for simple tools to assess asthma control. Two approaches considered were the monitoring of biometric markers of control and questionnaires to record patient-reported outcomes. Second, to understand the reasons for poor control for individual patients, identifying both clinical (e.g. rhinitis) and behavioural factors (e.g. smoking and nonadherence to treatment). Third was the need to incorporate, within asthma review, an assessment of patient perspectives including their goals and aspirations and to elicit their beliefs and concerns about asthma and its treatment. This can be used as a basis for agreement between the healthcare professional and patient on a predefined target regarding asthma control and a treatment plan to achieve this.

Summary

Optimum review of asthma is essential to improve control. A key priority is the development of simple and effective tools for identifying poor control for individual patients coupled with a tailored approach to treatment to enable patients to set and achieve realistic goals for asthma control.
Appendix
Available only for authorised users
Literature
2.
go back to reference BTS British Thoracic Society/Scottish Intercollegiate Guidelines Network: Guidelines on asthma management. Thorax. 2003, 58 (suppl 1): i1-i94. BTS British Thoracic Society/Scottish Intercollegiate Guidelines Network: Guidelines on asthma management. Thorax. 2003, 58 (suppl 1): i1-i94.
3.
go back to reference Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE: Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. American Journal of Respiratory Critical Care Medicine. 2004, 170 (8): 836-844. 10.1164/rccm.200401-033OC.CrossRefPubMed Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE: Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. American Journal of Respiratory Critical Care Medicine. 2004, 170 (8): 836-844. 10.1164/rccm.200401-033OC.CrossRefPubMed
4.
go back to reference Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA: Asthma programme in Finland: a community problem needs community solutions. Thorax. 2001, 56 (10): 806-814. 10.1136/thorax.56.10.806.CrossRefPubMedPubMedCentral Haahtela T, Klaukka T, Koskela K, Erhola M, Laitinen LA: Asthma programme in Finland: a community problem needs community solutions. Thorax. 2001, 56 (10): 806-814. 10.1136/thorax.56.10.806.CrossRefPubMedPubMedCentral
5.
go back to reference Barnes PJ, Jonsson B, Klim JB: The costs of asthma. European Respiratory Journal. 1996, 9 (4): 636-642. 10.1183/09031936.96.09040636.CrossRefPubMed Barnes PJ, Jonsson B, Klim JB: The costs of asthma. European Respiratory Journal. 1996, 9 (4): 636-642. 10.1183/09031936.96.09040636.CrossRefPubMed
6.
go back to reference Lamb HM, Culy CR, Faulds D: Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma. Pharmacoeconomics. 2000, 18 (5): 487-510. 10.2165/00019053-200018050-00008.CrossRefPubMed Lamb HM, Culy CR, Faulds D: Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma. Pharmacoeconomics. 2000, 18 (5): 487-510. 10.2165/00019053-200018050-00008.CrossRefPubMed
7.
go back to reference Hoskins G, McCowan C, Neville RG, Thomas GE, Smith B, Silverman S: Risk factors and costs associated with an asthma attack. Thorax. 2000, 55 (1): 19-24. 10.1136/thorax.55.1.19.CrossRefPubMedPubMedCentral Hoskins G, McCowan C, Neville RG, Thomas GE, Smith B, Silverman S: Risk factors and costs associated with an asthma attack. Thorax. 2000, 55 (1): 19-24. 10.1136/thorax.55.1.19.CrossRefPubMedPubMedCentral
8.
go back to reference Lane S, Molina J, Plusa T: An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respiratory Medicine. 2006, 100 (3): 434-450. 10.1016/j.rmed.2005.06.012.CrossRefPubMed Lane S, Molina J, Plusa T: An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respiratory Medicine. 2006, 100 (3): 434-450. 10.1016/j.rmed.2005.06.012.CrossRefPubMed
9.
go back to reference Williams AE, Lloyd AC, Rabe KF: Reduced cost of unscheduled healthcare resource use in patients with well-controlled asthma. Eur Respir J. 2005, 26 (suppl 49): 44s- Williams AE, Lloyd AC, Rabe KF: Reduced cost of unscheduled healthcare resource use in patients with well-controlled asthma. Eur Respir J. 2005, 26 (suppl 49): 44s-
10.
go back to reference Horne R: Beliefs and adherence to treatment: the challenge for research and clinical practice. The Power of Belief: Psychosocial Influence on Illness, Disability and Medicine. Edited by: Halligan, P.W., Aylward, M. 2006, Oxford , Oxford University Press, 115 -1136.CrossRef Horne R: Beliefs and adherence to treatment: the challenge for research and clinical practice. The Power of Belief: Psychosocial Influence on Illness, Disability and Medicine. Edited by: Halligan, P.W., Aylward, M. 2006, Oxford , Oxford University Press, 115 -1136.CrossRef
11.
go back to reference Rabe KF, Vermeire PA, Soriano JB, Maier WC: Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. European Respiratory Journal. 2000, 16 (5): 802-807. 10.1183/09031936.00.16580200.CrossRefPubMed Rabe KF, Vermeire PA, Soriano JB, Maier WC: Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. European Respiratory Journal. 2000, 16 (5): 802-807. 10.1183/09031936.00.16580200.CrossRefPubMed
12.
go back to reference Partridge MR, van der Molen T, Myrseth SE, Busse WW: Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006, 6 (13): Partridge MR, van der Molen T, Myrseth SE, Busse WW: Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006, 6 (13):
13.
go back to reference Thomas M, McKinley RK, Freeman E, Foy C, Prodger P, Price D: Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thorax. 2003, 58 (2): 110-115. 10.1136/thorax.58.2.110.CrossRefPubMedPubMedCentral Thomas M, McKinley RK, Freeman E, Foy C, Prodger P, Price D: Breathing retraining for dysfunctional breathing in asthma: a randomised controlled trial. Thorax. 2003, 58 (2): 110-115. 10.1136/thorax.58.2.110.CrossRefPubMedPubMedCentral
14.
go back to reference Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D: Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics. 2005, 115 (1): 129-134.PubMed Thomas M, Kocevar VS, Zhang Q, Yin DD, Price D: Asthma-related health care resource use among asthmatic children with and without concomitant allergic rhinitis. Pediatrics. 2005, 115 (1): 129-134.PubMed
15.
go back to reference Price D, Wolfe S: Patients' use and views on the service provided. Asthma Journal. 2000, 5: 141-144. Price D, Wolfe S: Patients' use and views on the service provided. Asthma Journal. 2000, 5: 141-144.
16.
go back to reference Price D, Ryan D, Pearce L, Bride F: The AIR study: asthma in real life. Asthma Journal. 1999, 4: 74-78. Price D, Ryan D, Pearce L, Bride F: The AIR study: asthma in real life. Asthma Journal. 1999, 4: 74-78.
17.
go back to reference Juniper EF, Chauhan A, Neville E, Chatterjee A, Svensson K, Mork AC, Stahl E: Clinicians tend to overestimate improvements in asthma control: an unexpected observation. Primary Care Respiratory Journal. 2004, 13 (4): 181-184. 10.1016/j.pcrj.2004.04.003.CrossRefPubMed Juniper EF, Chauhan A, Neville E, Chatterjee A, Svensson K, Mork AC, Stahl E: Clinicians tend to overestimate improvements in asthma control: an unexpected observation. Primary Care Respiratory Journal. 2004, 13 (4): 181-184. 10.1016/j.pcrj.2004.04.003.CrossRefPubMed
18.
go back to reference Boulet LP, Phillips R, O'Byrne P, Becker A: Evaluation of asthma control by physicians and patients: comparison with current guidelines. Canadian Respiratory Journal. 2002, 9 (6): 417-423.CrossRefPubMed Boulet LP, Phillips R, O'Byrne P, Becker A: Evaluation of asthma control by physicians and patients: comparison with current guidelines. Canadian Respiratory Journal. 2002, 9 (6): 417-423.CrossRefPubMed
19.
go back to reference Cochrane GM, Horne R, Chanez P: Compliance in asthma. Respiratory Medicine. 1999, 93 (11): 763-769. 10.1016/S0954-6111(99)90260-3.CrossRefPubMed Cochrane GM, Horne R, Chanez P: Compliance in asthma. Respiratory Medicine. 1999, 93 (11): 763-769. 10.1016/S0954-6111(99)90260-3.CrossRefPubMed
20.
go back to reference Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC: Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax. 2005, 60 (4): 282-287. 10.1136/thx.2004.033688.CrossRefPubMedPubMedCentral Tomlinson JE, McMahon AD, Chaudhuri R, Thompson JM, Wood SF, Thomson NC: Efficacy of low and high dose inhaled corticosteroid in smokers versus non-smokers with mild asthma. Thorax. 2005, 60 (4): 282-287. 10.1136/thx.2004.033688.CrossRefPubMedPubMedCentral
21.
go back to reference National Asthma Campaign: Out in the open: A true picture of asthma in the United Kingdom today. National Asthma Campaign Audit 2001. Asthma Journal. 2001, 6 (suppl): 1-14. National Asthma Campaign: Out in the open: A true picture of asthma in the United Kingdom today. National Asthma Campaign Audit 2001. Asthma Journal. 2001, 6 (suppl): 1-14.
22.
go back to reference Lai CK, De Guia TS, Kim YY, Kuo SH, Mukhopadhyay A, Soriano JB, Trung PL, Zhong NS, Zainudin N, Zainudin BM: Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. Journal of Allergy and Clinical Immunology. 2003, 111 (2): 263-268. 10.1067/mai.2003.30.CrossRefPubMed Lai CK, De Guia TS, Kim YY, Kuo SH, Mukhopadhyay A, Soriano JB, Trung PL, Zhong NS, Zainudin N, Zainudin BM: Asthma control in the Asia-Pacific region: the Asthma Insights and Reality in Asia-Pacific Study. Journal of Allergy and Clinical Immunology. 2003, 111 (2): 263-268. 10.1067/mai.2003.30.CrossRefPubMed
23.
go back to reference Haughney J, Barnes G, Partridge M, Cleland J: The Living & Breathing Study: a study of patients' views of asthma and its treatment. Primary Care Respiratory Journal. 2004, 13 (1): 28-35. 10.1016/j.pcrj.2003.11.007.CrossRefPubMed Haughney J, Barnes G, Partridge M, Cleland J: The Living & Breathing Study: a study of patients' views of asthma and its treatment. Primary Care Respiratory Journal. 2004, 13 (1): 28-35. 10.1016/j.pcrj.2003.11.007.CrossRefPubMed
25.
go back to reference Osman LM, McKenzie L, Cairns J, Friend JA, Godden DJ, Legge JS, Douglas JG: Patient weighting of importance of asthma symptoms. Thorax. 2001, 56 (2): 138-142. 10.1136/thorax.56.2.138.CrossRefPubMedPubMedCentral Osman LM, McKenzie L, Cairns J, Friend JA, Godden DJ, Legge JS, Douglas JG: Patient weighting of importance of asthma symptoms. Thorax. 2001, 56 (2): 138-142. 10.1136/thorax.56.2.138.CrossRefPubMedPubMedCentral
26.
go back to reference Andersson F, Borg S, Stahl E: The impact of exacerbations on the asthmatic patient's preference scores. Journal of Asthma. 2003, 40 (6): 615-623. 10.1081/JAS-120019032.CrossRefPubMed Andersson F, Borg S, Stahl E: The impact of exacerbations on the asthmatic patient's preference scores. Journal of Asthma. 2003, 40 (6): 615-623. 10.1081/JAS-120019032.CrossRefPubMed
27.
go back to reference Johansson G, Stallberg B, Tornling G, Andersson S, Karlsson GS, Falt K, Berggren F: Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest. 2004, 125 (3): 916-923. 10.1378/chest.125.3.916.CrossRefPubMed Johansson G, Stallberg B, Tornling G, Andersson S, Karlsson GS, Falt K, Berggren F: Asthma treatment preference study: a conjoint analysis of preferred drug treatments. Chest. 2004, 125 (3): 916-923. 10.1378/chest.125.3.916.CrossRefPubMed
28.
go back to reference Adams RJ, Smith BJ, Ruffin RE: Patient preferences for autonomy in decision making in asthma management. Thorax. 2001, 56 (2): 126-132. 10.1136/thorax.56.2.126.CrossRefPubMedPubMedCentral Adams RJ, Smith BJ, Ruffin RE: Patient preferences for autonomy in decision making in asthma management. Thorax. 2001, 56 (2): 126-132. 10.1136/thorax.56.2.126.CrossRefPubMedPubMedCentral
29.
go back to reference Beck AT: Cognitive therapy and emotional disorders. 1976, New York , International Universities Press Beck AT: Cognitive therapy and emotional disorders. 1976, New York , International Universities Press
30.
go back to reference Laing RD: The voice of experience. 1982, New York , Pantheon Laing RD: The voice of experience. 1982, New York , Pantheon
31.
go back to reference Kruithof N, Cleland J, Moffat M, Crescenzi K, Price D: Patient set treatment goals: a tool to measure patients' perceptions of changes in asthma outcomes. Primary Care Respiratory Journal. 2004, 13: 118-119. Kruithof N, Cleland J, Moffat M, Crescenzi K, Price D: Patient set treatment goals: a tool to measure patients' perceptions of changes in asthma outcomes. Primary Care Respiratory Journal. 2004, 13: 118-119.
32.
go back to reference Kruithof N, Cleland J, Bose A, Deshpande A, Triegaardt J, Price D: Patient set treatment goals: a more sensitive measure of change than standard symptom questions. Primary Care Respiratory Journal. 2004, 13: 119- Kruithof N, Cleland J, Bose A, Deshpande A, Triegaardt J, Price D: Patient set treatment goals: a more sensitive measure of change than standard symptom questions. Primary Care Respiratory Journal. 2004, 13: 119-
34.
go back to reference DiMatteo MR: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care. 2004, 42 (3): 200-209. 10.1097/01.mlr.0000114908.90348.f9.CrossRefPubMed DiMatteo MR: Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Medical Care. 2004, 42 (3): 200-209. 10.1097/01.mlr.0000114908.90348.f9.CrossRefPubMed
35.
go back to reference Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben Joseph RH: Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest. 2000, 117 (2): 542-550. 10.1378/chest.117.2.542.CrossRefPubMed Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben Joseph RH: Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest. 2000, 117 (2): 542-550. 10.1378/chest.117.2.542.CrossRefPubMed
36.
go back to reference Claxton AJ, Cramer J, Pierce C: A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001, 23 (8): 1296-1310. 10.1016/S0149-2918(01)80109-0.CrossRefPubMed Claxton AJ, Cramer J, Pierce C: A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001, 23 (8): 1296-1310. 10.1016/S0149-2918(01)80109-0.CrossRefPubMed
37.
go back to reference Horne R, Weinman J, Barber N, Elliott RA, Morgan M: Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities. 2005, London , National Co-ordinating Centre for NHS Service Delivery and Organisation NCCSDO Horne R, Weinman J, Barber N, Elliott RA, Morgan M: Concordance, adherence and compliance in medicine taking: a conceptual map and research priorities. 2005, London , National Co-ordinating Centre for NHS Service Delivery and Organisation NCCSDO
38.
go back to reference Weinman J: Providing written information for patients: psychological considerations. Journal of the Royal Society of Medicine. 1990, 83 (5): 303-305.PubMedPubMedCentral Weinman J: Providing written information for patients: psychological considerations. Journal of the Royal Society of Medicine. 1990, 83 (5): 303-305.PubMedPubMedCentral
39.
go back to reference Horne R: Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006, 130 (1 Suppl): 65S-72S. 10.1378/chest.130.1_suppl.65S.CrossRefPubMed Horne R: Compliance, adherence, and concordance: implications for asthma treatment. Chest. 2006, 130 (1 Suppl): 65S-72S. 10.1378/chest.130.1_suppl.65S.CrossRefPubMed
40.
go back to reference Horne R: Treatment perceptions and self regulation. The self-regulation of health and illness behaviour. Edited by: Cameron LD, Leventhal H. 2003, London , Routledge, 138-153. Horne R: Treatment perceptions and self regulation. The self-regulation of health and illness behaviour. Edited by: Cameron LD, Leventhal H. 2003, London , Routledge, 138-153.
41.
go back to reference Butler JA, Peveler RC, Roderick P, Smith PWF, Horne R, Mason JC: Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross sectional study. Nephrology Dialysis Transplantation. 2004, 19 (12): 3144-3149. 10.1093/ndt/gfh505.CrossRef Butler JA, Peveler RC, Roderick P, Smith PWF, Horne R, Mason JC: Modifiable risk factors for non-adherence to immunosuppressants in renal transplant recipients: a cross sectional study. Nephrology Dialysis Transplantation. 2004, 19 (12): 3144-3149. 10.1093/ndt/gfh505.CrossRef
42.
go back to reference Aikens JE, Nease DE, Nau DP, Klinkman MS, Schwenk TL: Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med. 2005, 3 (1): 23-30. 10.1370/afm.238.CrossRefPubMedPubMedCentral Aikens JE, Nease DE, Nau DP, Klinkman MS, Schwenk TL: Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med. 2005, 3 (1): 23-30. 10.1370/afm.238.CrossRefPubMedPubMedCentral
43.
go back to reference Horne R: Measuring adherence: the case for self-report. International Journal of Behavioural Medicine. 2004, 11 (Suppl): 75- Horne R: Measuring adherence: the case for self-report. International Journal of Behavioural Medicine. 2004, 11 (Suppl): 75-
44.
go back to reference Horne R, Weinman J: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research. 1999, 47 (6): 555-567. 10.1016/S0022-3999(99)00057-4.CrossRefPubMed Horne R, Weinman J: Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research. 1999, 47 (6): 555-567. 10.1016/S0022-3999(99)00057-4.CrossRefPubMed
45.
go back to reference Horne R, Weinman J: Self regulation and self management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychology and Health. 2002, 17 (1): 17-32. 10.1080/08870440290001502.CrossRef Horne R, Weinman J: Self regulation and self management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychology and Health. 2002, 17 (1): 17-32. 10.1080/08870440290001502.CrossRef
46.
go back to reference Halm EA, Mora P, Leventhal H: No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest. 2006, 129 (3): 573-580. 10.1378/chest.129.3.573.CrossRefPubMed Halm EA, Mora P, Leventhal H: No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma. Chest. 2006, 129 (3): 573-580. 10.1378/chest.129.3.573.CrossRefPubMed
47.
go back to reference Horne R, Weinman J, Hankins M: The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health. 1999, 14: 1-24.CrossRef Horne R, Weinman J, Hankins M: The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health. 1999, 14: 1-24.CrossRef
48.
go back to reference Ernst E: Complementary therapies for asthma: what patients use. Journal of Asthma. 1998, 35 (8): 667-671.CrossRefPubMed Ernst E: Complementary therapies for asthma: what patients use. Journal of Asthma. 1998, 35 (8): 667-671.CrossRefPubMed
49.
go back to reference Petrie KJ, Cameron L, Ellis CJ, Buick D, Weinman J: Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosomatic Medicine. 2002, 64 : 580-586.CrossRefPubMed Petrie KJ, Cameron L, Ellis CJ, Buick D, Weinman J: Changing illness perceptions after myocardial infarction: an early intervention randomized controlled trial. Psychosomatic Medicine. 2002, 64 : 580-586.CrossRefPubMed
50.
go back to reference Kullowatz A, Kanniess F, Dahme B, Magnussen H, Ritz T: Association of depression and anxiety with health care use and quality of life in asthma patients. Respiratory Medicine. Kullowatz A, Kanniess F, Dahme B, Magnussen H, Ritz T: Association of depression and anxiety with health care use and quality of life in asthma patients. Respiratory Medicine.
51.
go back to reference Rimington LD, Davies DH, Lowe D, Pearson MG: Relationship between anxiety, depression, and morbidity in adult asthma patients. Thorax. 2001, 56 (4): 266-271. 10.1136/thorax.56.4.266.CrossRefPubMedPubMedCentral Rimington LD, Davies DH, Lowe D, Pearson MG: Relationship between anxiety, depression, and morbidity in adult asthma patients. Thorax. 2001, 56 (4): 266-271. 10.1136/thorax.56.4.266.CrossRefPubMedPubMedCentral
52.
go back to reference Netuveli G, Hurwitz B, Levy M, Fletcher M, Barnes G, Durham SR, Sheikh A: Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis. Lancet. 2005, 365 (9456): 312-317.CrossRefPubMed Netuveli G, Hurwitz B, Levy M, Fletcher M, Barnes G, Durham SR, Sheikh A: Ethnic variations in UK asthma frequency, morbidity, and health-service use: a systematic review and meta-analysis. Lancet. 2005, 365 (9456): 312-317.CrossRefPubMed
53.
go back to reference Schatz M, Kosinski M, Sorkness C, Li J, Marcus P, Murray J, Nathan R, Jhingran P: Comparison of two patient-based measures of asthma control: ACT and ACQ. Proceedings of the American Thoracic Society. 2005, 2(Abs): A255- Schatz M, Kosinski M, Sorkness C, Li J, Marcus P, Murray J, Nathan R, Jhingran P: Comparison of two patient-based measures of asthma control: ACT and ACQ. Proceedings of the American Thoracic Society. 2005, 2(Abs): A255-
54.
go back to reference Baker KM, Brand DA, Hen J: Classifying asthma: disagreement among specialists. Chest. 2003, 124 (6): 2156-2163. 10.1378/chest.124.6.2156.CrossRefPubMed Baker KM, Brand DA, Hen J: Classifying asthma: disagreement among specialists. Chest. 2003, 124 (6): 2156-2163. 10.1378/chest.124.6.2156.CrossRefPubMed
55.
go back to reference Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM: Asthma variability in patients previously treated with beta2-agonists alone. Journal of Allergy and Clinical Immunology. 2003, 112 (6): 1088-1094. 10.1016/j.jaci.2003.09.044.CrossRefPubMed Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM: Asthma variability in patients previously treated with beta2-agonists alone. Journal of Allergy and Clinical Immunology. 2003, 112 (6): 1088-1094. 10.1016/j.jaci.2003.09.044.CrossRefPubMed
56.
go back to reference Heaney LG, Robinson DS: Severe asthma treatment: need for characterising patients. Lancet. 2005, 365 (9463): 974-976. 10.1016/S0140-6736(05)71087-4.CrossRefPubMed Heaney LG, Robinson DS: Severe asthma treatment: need for characterising patients. Lancet. 2005, 365 (9463): 974-976. 10.1016/S0140-6736(05)71087-4.CrossRefPubMed
57.
go back to reference Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. American Journal of Respiratory and Critical Care Medicine. 1999, 159 (4 Pt 1): 1043-1051.CrossRefPubMed Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, Sterk PJ: Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. American Journal of Respiratory and Critical Care Medicine. 1999, 159 (4 Pt 1): 1043-1051.CrossRefPubMed
58.
go back to reference Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID: Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002, 360 (9347): 1715-1721. 10.1016/S0140-6736(02)11679-5.CrossRefPubMed Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID: Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002, 360 (9347): 1715-1721. 10.1016/S0140-6736(02)11679-5.CrossRefPubMed
59.
go back to reference Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New England Journal of Medicine. 2005, 352 (21): 2163-2173. 10.1056/NEJMoa043596.CrossRefPubMed Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR: Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. New England Journal of Medicine. 2005, 352 (21): 2163-2173. 10.1056/NEJMoa043596.CrossRefPubMed
60.
go back to reference Teeter JG, Bleecker ER: Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest. 1998, 113 (2): 272-277.CrossRefPubMed Teeter JG, Bleecker ER: Relationship between airway obstruction and respiratory symptoms in adult asthmatics. Chest. 1998, 113 (2): 272-277.CrossRefPubMed
61.
go back to reference Filippelli M, Duranti R, Gigliotti F, Bianchi R, Grazzini M, Stendardi L, Scano G: Overall contribution of chest wall hyperinflation to breathlessness in asthma. Chest. 2003, 124 (6): 2164-2170. 10.1378/chest.124.6.2164.CrossRefPubMed Filippelli M, Duranti R, Gigliotti F, Bianchi R, Grazzini M, Stendardi L, Scano G: Overall contribution of chest wall hyperinflation to breathlessness in asthma. Chest. 2003, 124 (6): 2164-2170. 10.1378/chest.124.6.2164.CrossRefPubMed
62.
go back to reference Goldstein MF, Veza BA, Dunsky EH, Dvorin DJ, Belecanech GA, Haralabatos IC: Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma. Chest. 2001, 119 (4): 1001-1010. 10.1378/chest.119.4.1001.CrossRefPubMed Goldstein MF, Veza BA, Dunsky EH, Dvorin DJ, Belecanech GA, Haralabatos IC: Comparisons of peak diurnal expiratory flow variation, postbronchodilator FEV(1) responses, and methacholine inhalation challenges in the evaluation of suspected asthma. Chest. 2001, 119 (4): 1001-1010. 10.1378/chest.119.4.1001.CrossRefPubMed
63.
go back to reference Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID: A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002, 121 (4): 1051-1057. 10.1378/chest.121.4.1051.CrossRefPubMed Hunter CJ, Brightling CE, Woltmann G, Wardlaw AJ, Pavord ID: A comparison of the validity of different diagnostic tests in adults with asthma. Chest. 2002, 121 (4): 1051-1057. 10.1378/chest.121.4.1051.CrossRefPubMed
64.
go back to reference Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID: The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clinical and Experimental Allergy. 2005, 35 (9): 1175-1179. 10.1111/j.1365-2222.2005.02314.x.CrossRefPubMed Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID: The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clinical and Experimental Allergy. 2005, 35 (9): 1175-1179. 10.1111/j.1365-2222.2005.02314.x.CrossRefPubMed
65.
go back to reference Fitzpatrick R, Davey C, Buxton MJ, Jones DR: Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess Rep. 1998, 2 (14): 1-74. Fitzpatrick R, Davey C, Buxton MJ, Jones DR: Evaluating patient-based outcome measures for use in clinical trials. Health Technol Assess Rep. 1998, 2 (14): 1-74.
66.
go back to reference The EuroQol Group: EuroQol: A new facility for the measurement of health-related quality of life. Health Policy. 1990, 16 (3): 199-208. 10.1016/0168-8510(90)90421-9.CrossRef The EuroQol Group: EuroQol: A new facility for the measurement of health-related quality of life. Health Policy. 1990, 16 (3): 199-208. 10.1016/0168-8510(90)90421-9.CrossRef
70.
go back to reference Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB: Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004, 113 (1): 59-65. 10.1016/j.jaci.2003.09.008.CrossRefPubMed Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB: Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004, 113 (1): 59-65. 10.1016/j.jaci.2003.09.008.CrossRefPubMed
71.
go back to reference Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999, 14 (4): 902-907. 10.1034/j.1399-3003.1999.14d29.x.CrossRefPubMed Juniper EF, O'Byrne PM, Guyatt GH, Ferrie PJ, King DR: Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999, 14 (4): 902-907. 10.1034/j.1399-3003.1999.14d29.x.CrossRefPubMed
73.
go back to reference Marcus P, Schatz M, Kosinski M, Sorkness C, Li J, Nathan R, Murray J, Jhingran P: Effectiveness of ACT and Rules of Two in screening and monitoring for asthma control. Proceedings of the American Thoracic Society. 2005, 2(Abs): A255- Marcus P, Schatz M, Kosinski M, Sorkness C, Li J, Nathan R, Murray J, Jhingran P: Effectiveness of ACT and Rules of Two in screening and monitoring for asthma control. Proceedings of the American Thoracic Society. 2005, 2(Abs): A255-
74.
go back to reference Haynes RB, McDonald H, Garg AX, Montague P: Interventions for helping patients to follow prescriptions for medications. CochraneDatabaseSystRev. 2002, 2000 (2): CD000011- Haynes RB, McDonald H, Garg AX, Montague P: Interventions for helping patients to follow prescriptions for medications. CochraneDatabaseSystRev. 2002, 2000 (2): CD000011-
75.
go back to reference Horne R: Compliance, adherence and concordance. Pharmacy Practice. Edited by: Taylor K, Harding G. 2001, London , Taylor and Francis, 165-184. Horne R: Compliance, adherence and concordance. Pharmacy Practice. Edited by: Taylor K, Harding G. 2001, London , Taylor and Francis, 165-184.
76.
go back to reference Tomkins S, Collins A: Promoting optimal self-care. Dorset and Somerset Strategic Health Authority. 2006 Tomkins S, Collins A: Promoting optimal self-care. Dorset and Somerset Strategic Health Authority. 2006
77.
go back to reference Clark N, Jones P, Keller S, Vermeire P: Patient factors and compliance with asthma therapy. Respiratory Medicine. 1999, 93 (12): 856-862. 10.1016/S0954-6111(99)90050-1.CrossRefPubMed Clark N, Jones P, Keller S, Vermeire P: Patient factors and compliance with asthma therapy. Respiratory Medicine. 1999, 93 (12): 856-862. 10.1016/S0954-6111(99)90050-1.CrossRefPubMed
78.
go back to reference Horne R, Musgrave S, Lee A, Price D: The Minimal Asthma Assessment Tool (MAAT): a new method for prioritising patients for primary care review by identifying poor asthma control and the causes of poor control. General Practice Airways Group Annual Scientific Conference. 2005, Crewe, UK Horne R, Musgrave S, Lee A, Price D: The Minimal Asthma Assessment Tool (MAAT): a new method for prioritising patients for primary care review by identifying poor asthma control and the causes of poor control. General Practice Airways Group Annual Scientific Conference. 2005, Crewe, UK
Metadata
Title
Can asthma control be improved by understanding the patient's perspective?
Authors
Rob Horne
David Price
Jen Cleland
Rui Costa
Donna Covey
Kevin Gruffydd-Jones
John Haughney
Svein Hoegh Henrichsen
Alan Kaplan
Arnulf Langhammer
Anders Østrem
Mike Thomas
Thys van der Molen
J Christian Virchow
Siân Williams
Publication date
01-12-2007
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2007
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/1471-2466-7-8

Other articles of this Issue 1/2007

BMC Pulmonary Medicine 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.